99m Tc-EDDA-HYNIC-D-Phe 1 ,Tyr 3 ]-Octreotide ( 99m Tc-EDDA/HYNIC-TOC) is a promising new radiopharmaceutical with the potential to replace [ 111 In-DTPA-D-Phe 1 ]-Octreotide ( 111 In-DTPA-OCT) as the radiopharmaceutical for somatostatin receptor scintigraphy due to the advantage of improved image
A freeze dried formulation for the preparation of 99mTc-[V]-DMS complex
β Scribed by E. Chiotellis; A. Varvarigou; S. Archimandritis; E. Gyftaki
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- French
- Weight
- 404 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
β¦ Synopsis
A freeze dried kit formulation for the preparation of 999c-[V]-DMS complex was developed, requiring a single step labeling procedure. Methods of analysis were also developed permitting identification of radiochemical impurities which may be resent in radiopharmaceutical solution. FjgmTc-[V]-DMS prepared by the kit method was evaluated in experimental animals and human volunteers. Data demonstrated that the complex formed after kit reconstitution shows tumor seeking properties. Thyroid medullary carcinoma in patients was successfully detected 2 hrs post administration.
π SIMILAR VOLUMES
To develop insoluble Sn2+ complexes for the preparation of 99mTc radiopharmaceuticals, the adsorption of Sn2+ to macroreticular chelating ion exchange resins having various functional groups was investigated. Among them, a resin containing aminophosphonic acid groups showed a high adsorption capacit
## Abstract In this study, the labeling method of levofloxacin with technetiumβ99m and its biological evaluation were described. ^99m^TcβLβFlox was synthesized via direct complexation with technetiumβ99m in the presence of stannous chloride dihydrate as reducing agent. The optimum amounts of the re
## Abstract Labeling of sparafloxacin with technetiumβ99m using stannous chloride as a reducing agent was investigated. Dependence of the yield of ^99m^Tcβsparafloxacin complex on the concentration of sparafloxacin, reducing agent, pH and reaction time was studied. Under optimum conditions, the lab